FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stefania Merighi

Research Profile

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Fabrizio Vincenzi; Pier Giovanni Baraldi; Pier Andrea Borea; Carmen Corciulo; Stefania Gessi; Stefania Merighi; Giulia Saponaro; Mojgan Aghazadeh Tabrizi; Martina Targa; Katia Varani
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Fabrizio Vincenzi; Pier Andrea Borea; Carmen Corciulo; Stefania Gessi; Sarah Giacuzzo; Marcello Govoni; Stefania Merighi; Melissa Padovan; Martina Targa; Katia Varani
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
Stefania Gessi; Roberto Marci; Stefania Merighi; Prisco Mirandola; Alberto Sensi; Angela Stefanelli; Katia Varani; Alessandra Bonfatti; Pier Andrea Borea; Sergio Fini; Fortunato Vesce
Downregulation of A(1) and A(2B) adenosine receptors in human trisomy 21 mesenchymal cells from first-trimester chorionic villi.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stefania Merighi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Fabrizio Vincenzi; Pier Giovanni Baraldi; Pier Andrea Borea; Carmen Corciulo; Stefania Gessi; Stefania Merighi; Giulia Saponaro; Mojgan Aghazadeh Tabrizi; Martina Targa; Katia Varani
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models.
Pain 2013;154(6):864-73.
2013: Fabrizio Vincenzi; Pier Andrea Borea; Carmen Corciulo; Stefania Gessi; Sarah Giacuzzo; Marcello Govoni; Stefania Merighi; Melissa Padovan; Martina Targa; Katia Varani
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
PloS one 2013;8(1):e54195.
2012: Stefania Gessi; Roberto Marci; Stefania Merighi; Prisco Mirandola; Alberto Sensi; Angela Stefanelli; Katia Varani; Alessandra Bonfatti; Pier Andrea Borea; Sergio Fini; Fortunato Vesce
Downregulation of A(1) and A(2B) adenosine receptors in human trisomy 21 mesenchymal cells from first-trimester chorionic villi.
Biochimica et biophysica acta 2012;1822(11):1660-70.
2012: Stefania Merighi; Katia Varani; Debora Fazzi; Stefania Gessi; Pier Andrea Borea
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes.
Pharmacological research : the official journal of the Italian Pharmacological Society 2012;66(5):428-36.
2012: Stefania Merighi; Prisco Mirandola; Katia Varani; Debora Fazzi; Stefania Gessi; Pier Andrea Borea
Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells.
British journal of pharmacology 2012;166(8):2371-85.
2012: Pier Giovanni Baraldi; Stefania Baraldi; Pier Andrea Borea; Sandro Cosconati; Salvatore Di Maro; Stefania Gessi; Luciana Marinelli; Stefania Merighi; Allan R Moorman; Romeo Romagnoli; Giulia Saponaro; Katia Varani; Mojgan Aghazadeh Tabrizi; Delia Preti
Water-soluble pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as human A₃ adenosine receptor antagonists.
Journal of medicinal chemistry 2012;55(11):5380-90.
2012: Stefania Merighi; Prisco Mirandola; Carolina Simioni; Katia Varani; Debora Fazzi; Stefania Gessi; Pier Andrea Borea
Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.
British journal of pharmacology 2012;165(6):1773-88.
2012: Fabrizio Vincenzi; Pier Andrea Borea; Ruggero Cadossi; Carmen Corciulo; Stefania Gessi; Stefania Merighi; Stefania Setti; Martina Targa; Katia Varani
The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.
PloS one 2012;7(6):e39317.
2011: Stefania Gessi; Stefania Merighi; Angela Stefanelli; Katia Varani; Debora Fazzi; Pier Andrea Borea
Adenosine receptor targeting in health and disease.
Expert opinion on investigational drugs 2011;20(12):1591-609.
2011: Daniele Simoni; Caterina Virginio; Giuseppina Barbato; Riccardo Baruchello; Pier Andrea Borea; Andrea Bozzoli; Anna Maria Capelli; Riccardo Giovannini; Giuseppina Grisolia; Paolo Marchetti; Carla Marchioro; Stefania Merighi; Riccardo Rondanin; Cinzia Rullo; Daniele Donati
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-a.
Bioorganic & medicinal chemistry letters 2011;21(18):5423-7.
2010: Stefania Gessi; Valeria Sacchetto; Eleonora Fogli; Stefania Merighi; Katia Varani; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Edward Leung; Stephen Maclennan; Pier Andrea Borea
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors.
Biochemical pharmacology 2010;79(10):1483-95.
2010: Stefania Merighi; Carolina Simioni; Stefania Gessi; Katia Varani; Pier Andrea Borea
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors.
Biochemical pharmacology 2010;79(3):471-7.
2010: Stefania Gessi; Stefania Merighi; Pier Andrea Borea
Glucocorticoid's pharmacology: past, present and future.
Current pharmaceutical design 2010;16(32):3540-53.
2010: LUISA-CARLOTA LÓPEZ-CARA; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Stefania Gessi; Pier Andrea Borea; Stefania Merighi
Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug development.
Current medicinal chemistry 2010;17(30):3488-502.
2010: Stefania Gessi; Eleonora Fogli; Valeria Sacchetto; Stefania Merighi; Katia Varani; Delia Preti; Edward Leung; Stephen Maclennan; Pier Andrea Borea
Adenosine modulates HIF-1{alpha}, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(1):90-7.
2009: Stefania Merighi; Carolina Simioni; Stefania Gessi; Katia Varani; Prisco Mirandola; Mojgan Aghazadeh Tabrizi; Pier Giovanni Baraldi; Pier Andrea Borea
A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin.
Neoplasia (New York, N.Y.) 2009;11(10):1064-73.
2008: Katia Varani; Monica De Mattei; Fabrizio Vincenzi; Azzurra Tosi; Stefania Gessi; Stefania Merighi; Agnese Pellati; F Masieri; Alessia Ongaro; Pier Andrea Borea
Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2008;16(11):1421-9.
2008: Katia Varani; Annmarie Surprenant; Fabrizio Vincenzi; Alice Tosi; Stefania Gessi; Stefania Merighi; Pier Andrea Borea
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors.
Biochemical pharmacology 2008;75(5):1198-208.
2008: Katia Varani; Monica De Mattei; Fabrizio Vincenzi; Stefania Gessi; Stefania Merighi; Agnese Pellati; Alessia Ongaro; Angelo Caruso; Ruggero Cadossi; Pier Andrea Borea
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2008;16(3):292-304.
2008: Stefania Gessi; Eleonora Fogli; Valeria Sacchetto; Katia Varani; Stefania Merighi; Edward Leung; Stephen Mac Lennan; Pier Andrea Borea
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour.
Biochemical pharmacology 2008;75(2):562-9.
2008: Stefania Gessi; Stefania Merighi; Katia Varani; Edward Leung; Stephen Mac Lennan; Pier Andrea Borea
The A3 adenosine receptor: an enigmatic player in cell biology.
Pharmacology & therapeutics 2008;117(1):123-40.
2007: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Carolina Simioni; Edward Leung; Stephen Maclennan; Pier Giovanni Baraldi; Pier Andrea Borea
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Molecular pharmacology 2007;72(2):395-406.
2007: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen Maclennan; Pier Giovanni Baraldi; Pier Andrea Borea
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells.
Molecular pharmacology 2007;72(1):162-72.
2007: Stefania Gessi; Stefania Merighi; Katia Varani; Elena Cattabriga; Annalisa Benini; Prisco Mirandola; Edward Leung; Stephen Mac Lennan; Claudio F Feo; Stefania Baraldi; Pier Andrea Borea
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
Journal of cellular physiology 2007;211(3):826-36.
2007: Stefania Gessi; Katia Varani; Stefania Merighi; Eleonora Fogli; Valeria Sacchetto; Annalisa Benini; Edward Leung; Stephen Mac Lennan; Pier Andrea Borea
Adenosine and lymphocyte regulation.
Purinergic signalling 2007;3(1-2):109-16.
2006: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen Maclennan; Pier Giovanni Baraldi; Pier Andrea Borea
Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A₃ adenosine receptor.
Purinergic signalling 2006;2(4):627-32.
2006: Stefania Gessi; Katia Varani; Stefania Merighi; Edward Leung; Stephen Mac Lennan; Pier Giovanni Baraldi; Pier Andrea Borea
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptors.
Purinergic signalling 2006;2(4):583-8.
2006: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen Maclennan; Pier Andrea Borea
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells.
Biochemical pharmacology 2006;72(1):19-31.
2005: Katia Varani; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Elena Cattabriga; Annalisa Benini; Karl-Norbert Klotz; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Stephen Mac Lennan; Edward Leung; Pier Andrea Borea
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
Biochemical pharmacology 2005;70(11):1601-12.
2005: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen Maclennan; Pier Giovanni Baraldi; Pier Andrea Borea
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.
Neoplasia (New York, N.Y.) 2005;7(10):894-903.
2005: Katia Varani; Francesco Portaluppi; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Elena Cattabriga; Alessandro Dalpiaz; F Bortolotti; L Belardinelli; Pier Andrea Borea
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors.
Cellular and molecular life sciences : CMLS 2005;62(19-20):2350-8.
2005: Pier Giovanni Baraldi; Delia Preti; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; LUISA-CARLOTA LÓPEZ-CARA; Naser Abdel Zaid; Allan R Moorman; Stefania Merighi; Katia Varani; Pier Andrea Borea
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A3 adenosine receptor antagonists.
Journal of medicinal chemistry 2005;48(14):4697-701.
2005: Stefania Gessi; Katia Varani; Stefania Merighi; Elena Cattabriga; Cecilia Pancaldi; Youri Szabadkai; Rosario Rizzuto; Karl-Norbert Klotz; Edward Leung; Stephen Mac Lennan; Pier Giovanni Baraldi; Pier Andrea Borea
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
Molecular pharmacology 2005;67(6):2137-47.
2005: Stefania Merighi; Annalisa Benini; Prisco Mirandola; Stefania Gessi; Katia Varani; Edward Leung; Stephen Maclennan; Pier Andrea Borea
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
The Journal of biological chemistry 2005;280(20):19516-26.
2005: Daniele Simoni; Marcello Rossi; Valerio Bertolasi; Marinella Roberti; Daniela Pizzirani; Riccardo Rondanin; Riccardo Baruchello; Francesco Paolo Invidiata; Manlio Tolomeo; Stefania Grimaudo; Stefania Merighi; Katia Varani; Stefania Gessi; Pier Andrea Borea; Silvia Marino; Sabrina Cavallini; Clementina Bianchi; Anna Siniscalchi
Synthesis and pharmacology of 6-substituted benztropines: discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter.
Journal of medicinal chemistry 2005;48(9):3337-43.
2005: Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; LUISA-CARLOTA LÓPEZ-CARA; Francesca Fruttarolo; Stefania Merighi; Katia Varani; Stefania Gessi; Pier Andrea Borea
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A3 adenosine receptors in human tumor cell lines.
Current medicinal chemistry 2005;12(11):1319-29.
2004: Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Delia Preti; Andrea Bovero; Francesca Fruttarolo; LUISA-CARLOTA LÓPEZ-CARA; Allan R Moorman; Stefania Gessi; Stefania Merighi; Katia Varani; Pier Andrea Borea
[3H]-MRE 2029-F20, a selective antagonist radioligand for the human A2B adenosine receptors.
Bioorganic & medicinal chemistry letters 2004;14(13):3607-10.
2004: Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Delia Preti; Andrea Bovero; LUISA-CARLOTA LÓPEZ-CARA; Francesca Fruttarolo; Naser Abdel Zaid; Allan R Moorman; Katia Varani; Stefania Gessi; Stefania Merighi; Pier Andrea Borea
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Journal of medicinal chemistry 2004;47(6):1434-47.
2004: Stefania Gessi; Katia Varani; Stefania Merighi; Elena Cattabriga; Arianna Avitabile; Riccardo Gavioli; Cinzia Fortini; Edward Leung; Stephen Mac Lennan; Pier Andrea Borea
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation.
Molecular pharmacology 2004;65(3):711-9.
2004: Pier Andrea Borea; Katia Varani; Stefania Gessi; Stefania Merighi; Alessandro Dal Piaz; Paola Gilli; Gastone Gilli
Receptor binding thermodynamics at the neuronal nicotinic receptor.
Current topics in medicinal chemistry 2004;4(3):361-8.
2003: Katia Varani; Stefania Gessi; Stefania Merighi; Valeria Iannotta; Elena Cattabriga; Cecilia Pancaldi; Ruggero Cadossi; Pier Andrea Borea
Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields.
Biochemical pharmacology 2003;66(10):1897-906.
2003: Stefania Merighi; Prisco Mirandola; Katia Varani; Stefania Gessi; Edward Leung; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Pier Andrea Borea
A glance at adenosine receptors: novel target for antitumor therapy.
Pharmacology & therapeutics 2003;100(1):31-48.
2003: Stefania Merighi; Prisco Mirandola; Katia Varani; Stefania Gessi; Silvano Capitani; Edward Leung; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Pier Andrea Borea
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemotherapic drugs: taxol and vindesine.
Biochemical pharmacology 2003;66(5):739-48.
2003: Pier Giovanni Baraldi; Francesca Fruttarolo; Mojgan Aghazadeh Tabrizi; Delia Preti; LUISA-CARLOTA LÓPEZ-CARA; Hussein El-Kashef; Allan Moorman; Katia Varani; Stefania Gessi; Stefania Merighi; Pier Andrea Borea
Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Journal of medicinal chemistry 2003;46(7):1229-41.
2003: Pier Giovanni Baraldi; LUISA-CARLOTA LÓPEZ-CARA; Maria Giovanna Pavani; Maria del Carmen Nuñez; Mojgan Aghazadeh Tabrizi; John C Shryock; Edward Leung; Allan R Moorman; Canan Uluoglu; Valeria Iannotta; Stefania Merighi; Pier Andrea Borea
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
Journal of medicinal chemistry 2003;46(5):794-809.
2002: Stefania Merighi; Prisco Mirandola; Daniela Milani; Katia Varani; Stefania Gessi; Karl-Norbert Klotz; Edward Leung; Pier Giovanni Baraldi; Pier Andrea Borea
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.
The Journal of investigative dermatology 2002;119(4):923-33.
2002: Katia Varani; Stefania Gessi; Stefania Merighi; Valeria Iannotta; Elena Cattabriga; Susanna Spisani; Ruggero Cadossi; Pier Andrea Borea
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.
British journal of pharmacology 2002;136(1):57-66.
2002: Stefania Gessi; Katia Varani; Stefania Merighi; Elena Cattabriga; Valeria Iannotta; Edward Leung; Pier Giovanni Baraldi; Pier Andrea Borea
A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
Molecular pharmacology 2002;61(2):415-24.
2002: Stefania Merighi; Katia Varani; Stefania Gessi; Karl-Norbert Klotz; Edward Leung; Pier Giovanni Baraldi; Pier Andrea Borea
Binding thermodynamics at the human A(3) adenosine receptor.
Biochemical pharmacology 2002;63(2):157-61.
2001: Stefania Merighi; Katia Varani; Stefania Gessi; Elena Cattabriga; Valeria Iannotta; C Ulouglu; Edward Leung; Pier Andrea Borea
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
British journal of pharmacology 2001;134(6):1215-26.
2001: Stefania Gessi; Katia Varani; Stefania Merighi; Antonio Morelli; Davide Ferrari; Edward Leung; Pier Giovanni Baraldi; Giampiero Spalluto; Pier Andrea Borea
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
British journal of pharmacology 2001;134(1):116-26.
2001: Daniele Simoni; Marinella Roberti; Riccardo Rondanin; Riccardo Baruchello; Marcello Rossi; Francesco Paolo Invidiata; Stefania Merighi; Katia Varani; Stefania Gessi; Pier Andrea Borea; Silvia Marino; Sabrina Cavallini; Clementina Bianchi; Anna Siniscalchi
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter.
Bioorganic & medicinal chemistry letters 2001;11(6):823-7.
2000: P G Baraldi; Barbara Cacciari; R Romagnoli; Giampiero Spalluto; Stefano Moro; Karl-Norbert Klotz; E Leung; K Varani; Stefania Gessi; Stefania Merighi; P A Borea
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen.
Journal of medicinal chemistry 2000;43(25):4768-80.
2000: Katia Varani; Francesco Portaluppi; Stefania Gessi; Stefania Merighi; Ennio Ongini; L Belardinelli; Pier Andrea Borea
Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.
Circulation 2000;102(3):285-9.
2000: Katia Varani; Stefania Merighi; Stefania Gessi; Karl-Norbert Klotz; Edward Leung; Pier Giovanni Baraldi; Barbara Cacciari; LUISA-CARLOTA LÓPEZ-CARA; Giampiero Spalluto; Pier Andrea Borea
[(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
Molecular pharmacology 2000;57(5):968-75.
2000: Pier Giovanni Baraldi; Barbara Cacciari; LUISA-CARLOTA LÓPEZ-CARA; Stefania Merighi; Katia Varani; Pier Andrea Borea; Giampiero Spalluto
A(3) adenosine receptor ligands: history and perspectives.
Medicinal research reviews 2000;20(2):103-28.
2000: Pier Giovanni Baraldi; Barbara Cacciari; LUISA-CARLOTA LÓPEZ-CARA; Katia Varani; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Edward Leung; S L Hickey; Giampiero Spalluto
Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors.
Bioorganic & medicinal chemistry letters 2000;10(3):209-11.
2000: Stefania Gessi; Katia Varani; Stefania Merighi; Ennio Ongini; Pier Andrea Borea
A(2A) adenosine receptors in human peripheral blood cells.
British journal of pharmacology 2000;129(1):2-11.
1999: Pier Giovanni Baraldi; Barbara Cacciari; LUISA-CARLOTA LÓPEZ-CARA; Giampiero Spalluto; Karl-Norbert Klotz; E Leung; Katia Varani; Stefania Gessi; Stefania Merighi; Pier Andrea Borea
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists.
Journal of medicinal chemistry 1999;42(22):4473-8.
1999: Katia Varani; Francesco Portaluppi; Stefania Merighi; Ennio Ongini; L Belardinelli; Pier Andrea Borea
Caffeine alters A2A adenosine receptors and their function in human platelets.
Circulation 1999;99(19):2499-502.
1998: Katia Varani; Girolamo Calo; Anna Rizzi; Stefania Merighi; Géza Toth; Remo Guerrini; Severo Salvadori; Pier Andrea Borea; Domenico Regoli
Nociceptin receptor binding in mouse forebrain membranes: thermodynamic characteristics and structure activity relationships.
British journal of pharmacology 1998;125(7):1485-90.
1998: Prisco Mirandola; P Menegazzi; Stefania Merighi; T Ravaioli; Enzo Cassai; Dario Di Luca
Temporal mapping of transcripts in herpesvirus 6 variants.
Journal of virology 1998;72(5):3837-44.